Juan Lu Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2023	ALYREF mediates RNA m5C modification to promote hepatocellular carcinoma progression.
1/2023	Effects of 3-HAA on HCC by Regulating the Heterogeneous Macrophages-A scRNA-Seq Analysis.
10/2022	Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes.
3/2022	Functions and underlying mechanisms of miR-650 in human cancers.
1/2022	A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma.
1/2022	The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
1/2021	The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
1/2017	A tryptophan derivative, ITE, enhances liver cell metabolic functions in vitro.
6/2015	Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy.
9/2005	[Screening of cellular proteins binding to the core region of hepatitis C virus RNA by ultraviolet cross-linking assay].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan Lu Research Topics

Disease

61	Neoplasms (Cancer) 03/2024 - 06/2004
24	Nasopharyngeal Carcinoma 01/2023 - 04/2009
19	Inflammation (Inflammations) 04/2024 - 09/2010
15	Neoplasm Metastasis (Metastasis) 03/2024 - 04/2013
11	Infections 01/2024 - 06/2005
11	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 05/2003
9	Carcinogenesis 01/2024 - 03/2011
6	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2021 - 02/2007
5	Pneumonia (Pneumonitis) 01/2024 - 01/2017
5	Heart Failure 12/2023 - 11/2017
5	Stroke (Strokes) 09/2023 - 07/2007
4	Breast Neoplasms (Breast Cancer) 12/2023 - 02/2013
4	Ischemic Stroke 08/2022 - 10/2016
4	Hypoxia (Hypoxemia) 01/2022 - 09/2006
4	Insulin Resistance 01/2021 - 01/2013
4	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 01/2016
4	Hypersensitivity (Allergy) 01/2018 - 12/2017
3	Fibrosis (Cirrhosis) 02/2024 - 04/2019
3	Brain Ischemia (Cerebral Ischemia) 09/2023 - 05/2010
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2004
3	Sepsis (Septicemia) 09/2022 - 01/2020
3	Parkinson Disease (Parkinson's Disease) 10/2020 - 01/2019
3	Wounds and Injuries (Trauma) 06/2018 - 04/2012
3	Craniocerebral Trauma (Head Injury) 05/2012 - 08/2008
3	Hypotension (Low Blood Pressure) 08/2008 - 09/2006
3	Colonic Neoplasms (Colon Cancer) 06/2004 - 09/2003
2	Pathologic Processes 01/2024 - 01/2023
2	Myocarditis (Carditis) 01/2024 - 01/2023
2	Bites and Stings (Sting) 01/2024 - 11/2022
2	Myocardial Infarction 12/2023 - 01/2021
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2023 - 05/2010
2	Ischemia 08/2022 - 01/2022
2	COVID-19 12/2021 - 03/2021
2	Liver Failure 05/2021 - 08/2015
2	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2021
2	Obesity 01/2021 - 01/2013
2	Liver Diseases (Liver Disease) 01/2021 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2015
2	Chronic Renal Insufficiency 01/2021 - 05/2015

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2010
15	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2011
13	Proteins (Proteins, Gene)FDA Link 02/2024 - 09/2005
12	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 09/2003
7	Long Noncoding RNAIBA 01/2024 - 01/2021
7	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2022
7	CytokinesIBA 01/2024 - 01/2016
5	Glucose (Dextrose)FDA LinkGeneric 09/2023 - 02/2007
4	EnzymesIBA 03/2024 - 10/2009
4	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 12/2009
4	Oxygen (Dioxygen)IBA 12/2023 - 10/2019
4	Hemoglobins (Hemoglobin)IBA 08/2023 - 09/2006
3	Histones (Histone)IBA 02/2024 - 02/2004
3	AntigensIBA 01/2024 - 12/2014
3	neocryptolepineIBA 10/2023 - 10/2022
3	LipopolysaccharidesIBA 09/2022 - 04/2011
3	Messenger RNA (mRNA)IBA 01/2022 - 06/2009
3	C-Reactive ProteinIBA 01/2022 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2015
3	Epstein-Barr Virus Nuclear AntigensIBA 01/2020 - 08/2011
3	Nicotine FDA Link 01/2018 - 12/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2012 - 08/2008
3	Decitabine FDA Link 02/2004 - 09/2003
3	MethyltransferasesIBA 02/2004 - 09/2003
2	Tryptophan (L-Tryptophan)FDA Link 03/2024 - 10/2022
2	Enhancer of Zeste Homolog 2 ProteinIBA 02/2024 - 04/2013
2	N-methyladenosineIBA 01/2024 - 01/2022
2	VaccinesIBA 01/2024 - 01/2023
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2024 - 01/2018
2	ChemokinesIBA 01/2024 - 07/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 10/2010
2	AntioxidantsIBA 12/2023 - 12/2021
2	AntibodiesIBA 12/2023 - 01/2013
2	pterostilbeneIBA 09/2023 - 11/2020
2	Neuroprotective AgentsIBA 09/2023 - 01/2019
2	UbiquitinIBA 11/2022 - 08/2016
2	Antiviral Agents (Antivirals)IBA 11/2022 - 07/2014
2	radix ophiopogonis drug combination radix ginseng fructus schizandrae (Shen Mai)IBA 09/2022 - 01/2020
2	SolutionsIBA 08/2022 - 07/2016
2	AcidsIBA 08/2022 - 01/2017
2	Small Cytoplasmic RNAIBA 01/2022 - 01/2022
2	Circular RNAIBA 01/2022 - 11/2021
2	Interleukin-1 (Interleukin 1)IBA 01/2022 - 11/2017
2	Sincalide FDA Link 01/2022 - 02/2013
2	5-Methylcytosine (5 Methylcytosine)IBA 01/2022 - 08/2016
2	AlbuminsIBA 01/2022 - 01/2021
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 11/2017
2	AdiponectinIBA 01/2021 - 12/2020
2	Blood Proteins (Serum Proteins)IBA 01/2021 - 01/2019
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2021
2	Therapeutic UsesIBA 01/2021 - 12/2009
2	baicalinIBA 01/2021 - 04/2011
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 01/2017
2	LigandsIBA 01/2021 - 01/2017
2	Oxidopamine (6 Hydroxydopamine)IBA 10/2020 - 01/2019

Therapy/Procedure

22	Therapeutics 01/2024 - 12/2009
6	Drug Therapy (Chemotherapy) 01/2024 - 12/2009
5	Immunotherapy 01/2023 - 02/2016
2	Immunomodulation 01/2023 - 03/2021
2	Artificial Liver (Bioartificial Liver) 05/2021 - 01/2016
2	Lasers (Laser) 01/2021 - 01/2016